This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

DexCom To Present At Upcoming Investor Conferences

Stocks in this article: DXCM

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at several upcoming investor conferences. These conferences include:

  • Kevin Sayer, President, will present an update on DexCom at the Credit Suisse Healthcare Conference in Phoenix, AZ on Wednesday, November 9, 2011, at 4:30 p.m. (MST). The presentation, which will occur live at the Arizona Biltmore, will be concurrently webcast.
  • Terry Gregg, Chief Executive Officer, will present an update on DexCom at the Lazard Capital Markets 8 th Annual Healthcare Conference in New York City on Tuesday, November 15, 2011 at 9:00 a.m. (EST). The presentation, which will occur live at the Pierre, will be concurrently webcast.
  • Steven Pacelli, Chief Operating Officer, will present an update on DexCom at the Stephens Inc, Fall Investment Conference in New York City on Wednesday, November 16, 2011 at 9:30 a.m. (EST). The presentation, which will occur live at the New York Palace Hotel, will be concurrently webcast.
  • Terry Gregg will also present an update on DexCom at the 23 rd Annual Piper Jaffray Health Care Conference in New York City on Tuesday, November 29, 2011 at 1:00 p.m. (EST). The presentation, which will occur live at the New York Palace Hotel, will be concurrently webcast.
  • Terry Gregg will also present an update on DexCom at the Canaccord Genuity Cardiovascular , Aesthetics & Metabolic Disorders Conference in San Francisco, California on Tuesday, December 6 th, 2010, at 2:00 p.m. (PST). The presentation, which will occur live at the St. Regis in San Francisco, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com under the investor relations, events and webcast section, and will be archived for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs